✓ Editorial reviews of U.S. telehealth programs · Prices and dates shown on each page · Educational only — not medical advice
Guide

How Semaglutide Works — Mechanism Explained

Released: Last reviewed:

Semaglutide activates the GLP-1 receptor: glucose-dependent insulin secretion, glucagon suppression, slowed gastric emptying, reduced caloric intake.

Educational
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 20, 2026 · This page is informational and does not constitute medical advice.

Overview

Semaglutide activates the GLP-1 receptor: glucose-dependent insulin secretion, glucagon suppression, slowed gastric emptying, reduced caloric intake.

Related guides

Key facts, checked November 20, 2026

Per the Wegovy label, semaglutide is a GLP-1 analogue that activates the GLP-1 receptor, including in brain regions that regulate appetite and food intake, and it slows gastric emptying. In STEP 1 (NEJM 2021), that translated into 14.9% average weight loss at 68 weeks on 2.4 mg weekly, against 2.4% on placebo. The label says the exact mechanism of its cardiovascular benefit has not been established. Compounded semaglutide is not FDA-approved and was not the product tested, as FDA’s page on unapproved GLP-1 drugs notes.